Viewing nowTelmican Tablets 80 mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201209572 · Approved 2012.12.12 · Insurance code 645403880
Treatment of essential hypertension; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication is primarily used in patients with essential hypertension. It also helps reduce the risk of death and incidence of myocardial infarction and stroke caused by cardiovascular diseases in high-risk groups, such as those with coronary artery disease, stroke, and peripheral arterial disease. It can be given to patients who have difficulty taking angiotensin-converting enzyme (ACE) inhibitors, allowing for a safe expectation of therapeutic effects. Through these benefits, it contributes to blood pressure control and improvement of cardiovascular health.
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily with water, and it may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After starting treatment, the maximum blood pressure-lowering effect is achieved within 4 ∼ 8 weeks when the dose is increased. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. It should not be used in women who are pregnant or breastfeeding, patients with severe liver dysfunction, patients with hereditary angioedema, or those with diabetes or severe renal impairments. Elderly patients, patients with hyperkalemia, patients with slightly impaired liver function, patients with heart valve diseases, and patients with ischemic heart diseases should exercise caution before taking this medication. During treatment with this drug, side effects may occur such as infections, blood abnormalities, hyperkalemia, hypoglycemia, neurological symptoms, low blood pressure, dyspnea, gastrointestinal symptoms, liver function abnormalities, skin rashes, myalgia, and renal dysfunction. Patients should consult their healthcare provider immediately if symptoms arise. If angioedema, severe allergic reactions, renal function deterioration, shock symptoms, liver dysfunction, interstitial pneumonia, or rhabdomyolysis occur, treatment must be stopped immediately, and appropriate measures should be taken. Patients with reduced kidney function should regularly monitor serum potassium and creatinine levels, and patients with low blood volume or sodium levels are at risk of hypotension and should be cautious. Concomitant use with other antihypertensive medications may enhance the antihypertensive effects, so patients should inform their healthcare provider of any other medications they are taking. Medications that affect blood coagulation, lithium, certain diuretics, or non-steroidal anti-inflammatory drugs may increase the risk of side effects, and caution should be exercised when used together. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should avoid taking this medication as well. This medication is not recommended for children under the age of 18 as its safety and efficacy have not been established. In cases of overdose, symptoms may include low blood pressure, dizziness, and kidney dysfunction; immediate medical attention should be sought for appropriate treatment. During use, keep this medication out of reach of children, do not transfer it to other containers, and it is advisable to open the package just before consumption. While taking this medication, caution should be taken when driving or operating machinery, as dizziness or fainting may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius.
White or nearly white, double-convex, round tablet
30 tablets (10 tablets/Alu-Alu x3), 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.